Lower Respiratory Tract Infection
Respiratory
Prevalence
64.0 / 100K
Incidence
3138.8 / 100K/yr
7 drugs in development·6 companies·1 clinical trial
Drug Pipeline by Phase
Approved(6)
Phase 3(1)
| Drug | Company |
|---|---|
| nirsevimab | ASTRAZENECA PLC (AZN) |
Compare drugs
Frequently asked questions
How many drugs are in development for Lower Respiratory Tract Infection?
BioSniper tracks 7 drugs in development for Lower Respiratory Tract Infection across 6 companies.
How many clinical trials target Lower Respiratory Tract Infection?
There are 1 clinical trial targeting Lower Respiratory Tract Infection tracked by BioSniper.
What is the prevalence of Lower Respiratory Tract Infection?
The estimated prevalence of Lower Respiratory Tract Infection is approximately 64.0 per 100,000 population.
Deep-dive into Lower Respiratory Tract Infection
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis